COSA 2015*
Chairs: John Zalcberg & Andreas Adam
Evaluation of a web based cognitive rehabilitation programme (CRP) in cancer survivors reporting cognitive symptoms following chemotherapy (#18)
11:00 AM
The Lymphocyte-to-Monocyte ratio is a superior predictor of OS in comparison to established biomarkers in CRC patients undergoing curative resection. (#19)
11:15 AM
SIRFLOX: Randomised phase III trial comparing first-line mFOLFOX6 ± bevacizumab (bev) versus mFOLFOX6 ± bev + selective internal radiation therapy (SIRT) in patients with metastatic colorectal cancer (mCRC) - analysis by presence or absence of extra-hepatic metastases, bev treatment and site of first progression (#20)
11:30 AM
Density of Foxp3+ regulatory T cells correlates with radioresponsiveness in locally advanced rectal cancer (#21)
11:45 AM
Exploring the feasibility and utility of exome-scale sequencing of tumours in a clinical setting (#22)
12:00 PM
The impact of physical activity on fatigue and quality of life in lung cancer patients: a randomised controlled trial. (#23)
12:15 PM